Dilution profile // every instrument, one screen, from SEC filings

Syra Health Corp (SYRA)

CIK 1922335 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGHS-3/A on file 2025-02-05
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
LOW-1% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
LOW~56.9 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2023-11-102026-08-11

Latest: 13.8M shares as of Aug 11, 2026 (10-Q). Share count fell from 13.9M to 5.7M between Nov 10, 2023 and Mar 25, 2024, a pattern consistent with a reverse split (roughly 1-for-2); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

Balance-sheet fair value of warrants: $0 as of Oct 3, 2023.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 11, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

S-3Jan 24, 2025no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
S-1Aug 15, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 0 executed · 0 registered.

EFFECTIVEFeb 7, 2025SEC declared a registration effective — selling can beginEFFECT
REGISTEREDFeb 5, 2025S-3/A registration — capacity to sell shares, not a sale yetS-3/A
REGISTEREDJan 24, 2025S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDSep 12, 2024Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4
EFFECTIVESep 11, 2024SEC declared a registration effective — selling can beginEFFECT
REGISTEREDAug 15, 2024S-1 registration — capacity to sell shares, not a sale yetS-1
EXECUTEDOct 3, 2023Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4
REGISTEREDSep 28, 2023S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF
EFFECTIVESep 28, 2023SEC declared a registration effective — selling can beginEFFECT
REGISTEREDSep 13, 2023S-1/A registration — capacity to sell shares, not a sale yetS-1/A
MARKETINGSep 6, 2023Free-writing prospectus — offering being marketedFWP
REGISTEREDSep 5, 2023S-1/A registration — capacity to sell shares, not a sale yetS-1/A

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full SYRA workspace